Matthew Sullivan

663 total citations
21 papers, 510 citations indexed

About

Matthew Sullivan is a scholar working on Molecular Biology, Biomedical Engineering and Oncology. According to data from OpenAlex, Matthew Sullivan has authored 21 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Biomedical Engineering and 4 papers in Oncology. Recurrent topics in Matthew Sullivan's work include Innovative Microfluidic and Catalytic Techniques Innovation (3 papers), Cancer Cells and Metastasis (2 papers) and RNA modifications and cancer (2 papers). Matthew Sullivan is often cited by papers focused on Innovative Microfluidic and Catalytic Techniques Innovation (3 papers), Cancer Cells and Metastasis (2 papers) and RNA modifications and cancer (2 papers). Matthew Sullivan collaborates with scholars based in United States, Israel and South Korea. Matthew Sullivan's co-authors include Peter C. Dedon, José L. McFaline‐Figueroa, Min Dong, Koli Taghizadeh, Bo Pang, Elaine F. Plummer, Alan Cantor, Tyler B. Moran, Bo Pang and Richard P. Cunningham and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Blood.

In The Last Decade

Matthew Sullivan

20 papers receiving 505 citations

Peers

Matthew Sullivan

IMMUN

HEMAT

ONCOL

Shuzhen Liu China

Karl B. McCann Australia

Francesca Margheri Italy

Magdalena Głowala‐Kosińska Poland

Meng Ding China

Deliang Zhang China

Bettina Schmidt Germany

Luisa Vicari Italy

Guoyan Xu China

Kun Zhou China

Shuzhen Liu China

Matthew Sullivan

352 ×1.2

108 ×1.3

IMMUN

74 ×0.9

25 ×0.4

HEMAT

37 ×0.7

ONCOL

Citations per year, relative to Matthew Sullivan Matthew Sullivan (= 1×) peers Shuzhen Liu

Countries citing papers authored by Matthew Sullivan

Since Specialization

Citations

This map shows the geographic impact of Matthew Sullivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Sullivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Sullivan more than expected).

Fields of papers citing papers by Matthew Sullivan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Sullivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Sullivan. The network helps show where Matthew Sullivan may publish in the future.

Co-authorship network of co-authors of Matthew Sullivan

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Sullivan. A scholar is included among the top collaborators of Matthew Sullivan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Sullivan. Matthew Sullivan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sullivan, Matthew, et al.. (2024). Characterizing influence of rCHOP treatment on diffuse large B-cell lymphoma microenvironment through in vitro microfluidic spheroid model. Cell Death and Disease. 15(1). 18–18. 2 indexed citations

Sullivan, Matthew, et al.. (2024). Aplastic anaemia following antibiotic use for urinary tract infection. BMJ Case Reports. 17(2). e254547–e254547.

Zhong, Ruoyu, Matthew Sullivan, Roy Chen, et al.. (2023). Cellular immunity analysis by a modular acoustofluidic platform: CIAMAP. Science Advances. 9(51). eadj9964–eadj9964. 13 indexed citations

Ugolini, Giovanni Stefano, et al.. (2022). Droplet microfluidics for functional temporal analysis and cell recovery on demand using microvalves: application in immunotherapies for cancer. Lab on a Chip. 22(17). 3258–3267. 22 indexed citations

Kumari, Rajesh, Ji Won Lim, Matthew Sullivan, et al.. (2022). A Novel Rolling Circle Amplification-Based Detection of SARS-CoV-2 with Multi-Region Padlock Hybridization. Diagnostics. 12(9). 2252–2252. 11 indexed citations

Aluri, Krishna, Matthew Sullivan, Roman Manetsch, et al.. (2021). Cyclic Thiosulfinates as a Novel Class of Disulfide Cleavable Cross-Linkers for Rapid Hydrogel Synthesis. Bioconjugate Chemistry. 32(3). 584–594. 12 indexed citations

Greguš, Michal, Somak Ray, Matthew Sullivan, et al.. (2021). High-throughput microfluidic 3D biomimetic model enabling quantitative description of the human breast tumor microenvironment. Acta Biomaterialia. 132. 473–488. 38 indexed citations

Sullivan, Matthew, et al.. (2020). Quantifying the efficacy of checkpoint inhibitors on CD8+ cytotoxic T cells for immunotherapeutic applications via single-cell interaction. Cell Death and Disease. 11(11). 979–979. 16 indexed citations

Sullivan, Matthew, et al.. (2017). Rare presentation of a massive intermittent upper gastrointestinal bleed. International Journal of Case Reports and Images. 8(1). 30–30. 1 indexed citations

10.

Reagan, John L., et al.. (2015). Potential for improved survival with intensification of daunorubicin based induction chemotherapy in acute myeloid leukemia patients who do not receive transplant: A multicenter retrospective study. Leukemia Research. 39(8). 812–817. 2 indexed citations

11.

Sullivan, Matthew, Alexey V. Danilov, Frederick Lansigan, & Nancy M. Dunbar. (2014). Carfilzomib associated thrombotic microangiopathy initially treated with therapeutic plasma exchange. Journal of Clinical Apheresis. 30(5). 308–310. 30 indexed citations

12.

Prestwich, Erin G., Aswin Mangerich, Bo Pang, et al.. (2013). Increased Levels of Inosine in a Mouse Model of Inflammation. Chemical Research in Toxicology. 26(4). 538–546. 15 indexed citations

13.

Janakiram, Murali, et al.. (2013). A Systematic Review of the Utility of Residual Vein Obstruction Studies in Primary and Secondary Venous Thrombosis. PubMed. 2013. 1–9. 10 indexed citations

14.

Janakiram, Murali, et al.. (2012). Emerging Therapeutic Targets in Diffuse Large B-Cell Lymphoma. Current Treatment Options in Oncology. 13(1). 82–101. 2 indexed citations

15.

Pang, Bo, José L. McFaline‐Figueroa, Min Dong, et al.. (2012). Defects in purine nucleotide metabolism lead to substantial incorporation of xanthine and hypoxanthine into DNA and RNA. Proceedings of the National Academy of Sciences. 109(7). 2319–2324. 105 indexed citations

16.

Woo, Andrew J., Tyler B. Moran, Yocheved L. Schindler, et al.. (2008). Identification of ZBP-89 as a Novel GATA-1-Associated Transcription Factor Involved in Megakaryocytic and Erythroid Development. Molecular and Cellular Biology. 28(8). 2675–2689. 56 indexed citations

17.

Cantor, Alan, Hiromi Iwasaki, Yojiro Arinobu, et al.. (2008). Antagonism of FOG-1 and GATA factors in fate choice for the mast cell lineage. The Journal of Experimental Medicine. 205(3). 611–624. 62 indexed citations

18.

Taghizadeh, Koli, José L. McFaline‐Figueroa, Bo Pang, et al.. (2008). Quantification of DNA damage products resulting from deamination, oxidation and reaction with products of lipid peroxidation by liquid chromatography isotope dilution tandem mass spectrometry. Nature Protocols. 3(8). 1287–1298. 108 indexed citations

19.

Woo, Andrew J., Tyler B. Moran, Seong‐Kyu Choe, et al.. (2006). Identification of Zfp148 (ZBP-89) as a novel GATA-1 associated Kruppel-type zinc finger transcription factor required for megakaryopoiesis and definitive erythropoiesis. Blood Cells Molecules and Diseases. 38(2). 129–130. 1 indexed citations

20.

Woo, Andrew J., Tyler B. Moran, Seong‐Kyu Choe, et al.. (2005). Identification of zfp148 (ZBP-89) as a Novel GATA-1 Associated Transcription Factor Involved in Megakaryopoiesis and Definitive Erythropoiesis.. Blood. 106(11). 828–828. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact